A human ESC line for efficient CRISPR editing of pluripotent stem cells

被引：2
|
作者：
Sintov, Elad [1 ]
Gerace, Dario [1 ]
Melton, Douglas A. [1 ,2 ]
机构：
[1] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA
[2] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA
来源：
STEM CELL RESEARCH | 2021年 / 57卷
关键词：
D O I：
10.1016/j.scr.2021.102591
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Human pluripotent stem cells (hPSC) can be directed to differentiate in vitro into insulin-prorducing beta cells (SC-beta). Although these cells accurately respond to glucose and can reverse diabetes in preclinical models improvments in the final cell products are desirable. For example, safety, controlling the cellular compositions and protection against immune rejection may be addressed by genetic modifications of SC-beta pre-transplantation. To screen for gene targets, we have generated a human embryonic stem cell line (hESC) that constitutively express the enhanced specificity Streptococcus pyogenes Cas9 (eSpCas9) gene, knocked-in into the GAPDH locus.
引用
收藏
页数：4
相关论文
共 50 条
  • [11] A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells
    Geng, Bing-chuan
    Choi, Kyoung-Han
    Wang, Shan-zhi
    Chen, Peng
    Pan, Xiu-di
    Dong, Nian-guo
    Ko, Jae-Kyun
    Zhu, Hua
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (11) : 1427 - 1432
  • [12] Generation of an ICF Syndrome Model by Efficient Genome Editing of Human Induced Pluripotent Stem Cells Using the CRISPR System
    Horii, Takuro
    Tamura, Daiki
    Morita, Sumiyo
    Kimura, Mika
    Hatada, Izuho
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (10): : 19774 - 19781
  • [13] A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells
    Bing-chuan Geng
    Kyoung-Han Choi
    Shan-zhi Wang
    Peng Chen
    Xiu-di Pan
    Nian-guo Dong
    Jae-Kyun Ko
    Hua Zhu
    Acta Pharmacologica Sinica, 2020, 41 : 1427 - 1432
  • [14] DICE, an efficient system for iterative genomic editing in human pluripotent stem cells
    Zhu, Fangfang
    Gamboa, Matthew
    Farruggio, Alfonso P.
    Hippenmeyer, Simon
    Tasic, Bosiljka
    Schuele, Birgitt
    Chen-Tsai, Yanru
    Calos, Michele P.
    NUCLEIC ACIDS RESEARCH, 2014, 42 (05) : e34
  • [15] Small Molecules Enhance CRISPR Genome Editing in Pluripotent Stem Cells
    Yu, Chen
    Liu, Yanxia
    Ma, Tianhua
    Liu, Kai
    Xu, Shaohua
    Zhang, Yu
    Liu, Honglei
    La Russa, Marie
    Xie, Min
    Ding, Sheng
    Qi, Lei S.
    CELL STEM CELL, 2015, 16 (02) : 142 - 147
  • [16] CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells: Harnessing Human Genetics in a Dish
    Gonzalez, Federico
    DEVELOPMENTAL DYNAMICS, 2016, 245 (07) : 788 - 806
  • [17] Gene editing in naive human pluripotent stem cells
    Dodsworth, Benjamin
    Flynn, Rowan
    Meyer, Claas Aiko
    Cowley, Sally
    HUMAN GENE THERAPY, 2015, 26 (09) : A30 - A30
  • [18] A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells
    Jurlina, Shawna L.
    Jones, Melissa K.
    Agarwal, Devansh
    De la Toba, Diana, V
    Kambli, Netra
    Su, Fei
    Martin, Heather M.
    Anderson, Ryan
    Wong, Ryan M.
    Seid, Justin
    Attaluri, Saisantosh, V
    Chow, Melissa
    Wahlin, Karl J.
    GENES, 2022, 13 (12)
  • [19] Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing
    Yi, Tong
    Bai, Rui
    Sun, Hairui
    Lan, Feng
    Zhang, Hongjia
    He, Yihua
    STEM CELL RESEARCH, 2020, 47
  • [20] FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells
    Caillaud, Amandine
    Leveque, Antoine
    Thedrez, Aurelie
    Girardeau, Aurore
    Canac, Robin
    Bray, Lise
    Baudic, Manon
    Barc, Julien
    Gaborit, Nathalie
    Lamirault, Guillaume
    Gardie, Betty
    Idriss, Salam
    Rimbert, Antoine
    May, Cedric Le
    Cariou, Bertrand
    Si-Tayeb, Karim
    STAR PROTOCOLS, 2022, 3 (04):
12345